Chapter

Targeting Autophagy in Cancer Therapy

Part of the series Current Cancer Research pp 39-57

Date:

Small-Molecule Regulators of Autophagy as Potential Anti-cancer Therapy

  • Qing LiAffiliated withState Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
  • , Mi ZhouAffiliated withState Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
  • , Renxiao WangAffiliated withState Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences Email author 

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Autophagy is an evolutionary conserved lysosomal pathway functioned in the turnover of cellular macromolecules and organelles. It is known that autophagy can have a cytoprotective effect in tumor cells under therapeutic treatment. Autophagy inhibitors thus may be used as auxiliary drugs to augment the anti-tumor activity of cancer therapies. On the other hand, autophagy is a cytotoxic event that can kill tumor cells. Autophagy inducers that increase the level of autophagy thus may be developed as a new class of anti-cancer therapy. This chapter will describe the known pathway of autophagy and its relationship to cancer. The focus of this chapter is to give a summary of the known small-molecule regulators of autophagy, including inhibitors and inducers, discovered as potential therapies for cancer treatment.

Keywords

Autophagy Cell death Autophagy inhibitor Autophagy inducer Anti-cancer treatment